Seek Returns logo

IDXX vs. VEEV: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at IDXX and VEEV, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolIDXXVEEV
Company NameIDEXX Laboratories, Inc.Veeva Systems Inc.
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Equipment & SuppliesHealth Care Technology
Market Capitalization56.66 billion USD48.48 billion USD
ExchangeNasdaqGSNYSE
Listing DateJune 21, 1991October 16, 2013
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of IDXX and VEEV by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

IDXX vs. VEEV: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolIDXXVEEV
5-Day Price Return-1.74%0.77%
13-Week Price Return8.81%6.78%
26-Week Price Return45.82%24.10%
52-Week Price Return63.88%32.39%
Month-to-Date Return12.72%1.56%
Year-to-Date Return71.63%40.67%
10-Day Avg. Volume0.70M0.82M
3-Month Avg. Volume0.54M1.22M
3-Month Volatility35.41%28.35%
Beta1.671.04

Profitability

Return on Equity (TTM)

IDXX

67.78%

Health Care Equipment & Supplies Industry

Max
29.93%
Q3
16.99%
Median
9.28%
Q1
5.10%
Min
-12.52%

IDXX’s Return on Equity of 67.78% is exceptionally high, placing it well beyond the typical range for the Health Care Equipment & Supplies industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

VEEV

13.40%

Health Care Technology Industry

Max
48.09%
Q3
41.80%
Median
18.17%
Q1
11.64%
Min
11.05%

VEEV’s Return on Equity of 13.40% is on par with the norm for the Health Care Technology industry, indicating its profitability relative to shareholder equity is typical for the sector.

IDXX vs. VEEV: A comparison of their Return on Equity (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Net Profit Margin (TTM)

IDXX

24.65%

Health Care Equipment & Supplies Industry

Max
24.41%
Q3
13.71%
Median
10.08%
Q1
5.96%
Min
-5.58%

IDXX’s Net Profit Margin of 24.65% is exceptionally high, placing it well beyond the typical range for the Health Care Equipment & Supplies industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.

VEEV

27.29%

Health Care Technology Industry

Max
52.24%
Q3
49.15%
Median
33.59%
Q1
16.86%
Min
13.38%

VEEV’s Net Profit Margin of 27.29% is aligned with the median group of its peers in the Health Care Technology industry. This indicates its ability to convert revenue into profit is typical for the sector.

IDXX vs. VEEV: A comparison of their Net Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Operating Profit Margin (TTM)

IDXX

31.34%

Health Care Equipment & Supplies Industry

Max
31.09%
Q3
18.11%
Median
15.07%
Q1
8.48%
Min
-0.28%

IDXX’s Operating Profit Margin of 31.34% is exceptionally high, placing it well above the typical range for the Health Care Equipment & Supplies industry. This demonstrates outstanding efficiency in managing its core operations, which can be a result of strong pricing power or superior cost control.

VEEV

26.93%

Health Care Technology Industry

Max
74.05%
Q3
65.56%
Median
33.50%
Q1
22.83%
Min
21.46%

VEEV’s Operating Profit Margin of 26.93% is around the midpoint for the Health Care Technology industry, indicating that its efficiency in managing core business operations is typical for the sector.

IDXX vs. VEEV: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Profitability at a Glance

SymbolIDXXVEEV
Return on Equity (TTM)67.78%13.40%
Return on Assets (TTM)31.08%10.96%
Net Profit Margin (TTM)24.65%27.29%
Operating Profit Margin (TTM)31.34%26.93%
Gross Profit Margin (TTM)61.72%75.59%

Financial Strength

Current Ratio (MRQ)

IDXX

1.18

Health Care Equipment & Supplies Industry

Max
5.19
Q3
3.00
Median
2.13
Q1
1.44
Min
0.86

IDXX’s Current Ratio of 1.18 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

VEEV

5.57

Health Care Technology Industry

Max
6.49
Q3
6.49
Median
6.02
Q1
3.62
Min
2.96

VEEV’s Current Ratio of 5.57 aligns with the median group of the Health Care Technology industry, indicating that its short-term liquidity is in line with its sector peers.

IDXX vs. VEEV: A comparison of their Current Ratio (MRQ) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Debt-to-Equity Ratio (MRQ)

IDXX

0.63

Health Care Equipment & Supplies Industry

Max
1.61
Q3
0.76
Median
0.45
Q1
0.14
Min
0.00

IDXX’s Debt-to-Equity Ratio of 0.63 is typical for the Health Care Equipment & Supplies industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

VEEV

0.00

Health Care Technology Industry

Max
0.14
Q3
0.10
Median
0.01
Q1
0.00
Min
0.00

Falling into the lower quartile for the Health Care Technology industry, VEEV’s Debt-to-Equity Ratio of 0.00 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

IDXX vs. VEEV: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Interest Coverage Ratio (TTM)

IDXX

49.24

Health Care Equipment & Supplies Industry

Max
56.35
Q3
25.56
Median
9.60
Q1
3.78
Min
-26.49

IDXX’s Interest Coverage Ratio of 49.24 is in the upper quartile for the Health Care Equipment & Supplies industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.

VEEV

169.00

Health Care Technology Industry

Max
224.12
Q3
224.12
Median
219.00
Q1
219.00
Min
219.00

VEEV’s Interest Coverage Ratio of 169.00 is below the typical range for the Health Care Technology industry. This suggests a weaker ability to meet debt obligations compared to its peers and may indicate a higher level of financial risk.

IDXX vs. VEEV: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Financial Strength at a Glance

SymbolIDXXVEEV
Current Ratio (MRQ)1.185.57
Quick Ratio (MRQ)0.825.48
Debt-to-Equity Ratio (MRQ)0.630.00
Interest Coverage Ratio (TTM)49.24169.00

Growth

Revenue Growth

IDXX vs. VEEV: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

IDXX vs. VEEV: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

IDXX

0.00%

Health Care Equipment & Supplies Industry

Max
4.15%
Q3
1.76%
Median
0.79%
Q1
0.00%
Min
0.00%

IDXX currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

VEEV

0.00%

Health Care Technology Industry

Max
0.89%
Q3
0.70%
Median
0.15%
Q1
0.04%
Min
0.00%

VEEV currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

IDXX vs. VEEV: A comparison of their Dividend Yield (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Dividend Payout Ratio (TTM)

IDXX

0.00%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
66.60%
Median
27.49%
Q1
0.00%
Min
0.00%

IDXX has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

VEEV

0.00%

Health Care Technology Industry

Max
101.92%
Q3
87.10%
Median
42.63%
Q1
10.66%
Min
0.00%

VEEV has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

IDXX vs. VEEV: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Dividend at a Glance

SymbolIDXXVEEV
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

IDXX

54.60

Health Care Equipment & Supplies Industry

Max
67.29
Q3
47.01
Median
30.94
Q1
23.91
Min
10.79

A P/E Ratio of 54.60 places IDXX in the upper quartile for the Health Care Equipment & Supplies industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.

VEEV

58.28

Health Care Technology Industry

Max
280.41
Q3
225.12
Median
59.01
Q1
44.08
Min
39.20

VEEV’s P/E Ratio of 58.28 is within the middle range for the Health Care Technology industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

IDXX vs. VEEV: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Price-to-Sales Ratio (TTM)

IDXX

13.46

Health Care Equipment & Supplies Industry

Max
9.49
Q3
5.41
Median
2.86
Q1
2.07
Min
0.74

With a P/S Ratio of 13.46, IDXX trades at a valuation that eclipses even the highest in the Health Care Equipment & Supplies industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

VEEV

15.90

Health Care Technology Industry

Max
146.49
Q3
115.78
Median
19.83
Q1
7.94
Min
5.25

VEEV’s P/S Ratio of 15.90 aligns with the market consensus for the Health Care Technology industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

IDXX vs. VEEV: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Price-to-Book Ratio (MRQ)

IDXX

32.74

Health Care Equipment & Supplies Industry

Max
10.85
Q3
6.56
Median
3.53
Q1
2.36
Min
0.71

At 32.74, IDXX’s P/B Ratio is at an extreme premium to the Health Care Equipment & Supplies industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

VEEV

7.00

Health Care Technology Industry

Max
115.01
Q3
89.07
Median
9.11
Q1
4.04
Min
3.06

VEEV’s P/B Ratio of 7.00 is within the conventional range for the Health Care Technology industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

IDXX vs. VEEV: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Valuation at a Glance

SymbolIDXXVEEV
Price-to-Earnings Ratio (TTM)54.6058.28
Price-to-Sales Ratio (TTM)13.4615.90
Price-to-Book Ratio (MRQ)32.747.00
Price-to-Free Cash Flow Ratio (TTM)59.6735.54
IDXX vs. VEEV: A Head-to-Head Stock Comparison